A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies.
Rifkind Award winners, left-to-right: Janel Long-Boyle, PharmD, PhD; Caroline Lindsay, PharmD; Elisabeth Birdsall, PharmD
Studies of cancer drug dosing in children, possible medication links to delirium in hospital patients, and how to decide when swallowed batteries may call for invasive removal took top honors at the Department of Clinical Pharmacy’s 14th annual Spring Research Seminar.
